Journal Of Cardiovascular Pharmacology And Therapeutics

Journal Of Cardiovascular Pharmacology And Therapeutics

心血管药理学与治疗学杂志

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Journal Of Cardiovascular Pharmacology And Therapeutics》是由SAGE Publications Ltd出版社于1996年创办的英文国际期刊(ISSN: 1074-2484,E-ISSN: 1940-4034),该期刊长期致力于心脏和心血管系统领域的创新研究,主要研究方向为医学-心血管系统。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0682...%),以发表心脏和心血管系统领域等方向的原创性研究为核心(研究类文章占比70.37%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在27篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Cardiovascular Pharmacology And Therapeutics审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约27篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 27 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 90 / 220

59.3%

学科:PHARMACOLOGY & PHARMACY SCIE Q3 180 / 354

49.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q3 111 / 220

49.77%

学科:PHARMACOLOGY & PHARMACY SCIE Q3 215 / 354

39.41%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6 SJR:0.696 SNIP:0.682
学科类别 分区 排名 百分位
大类:Medicine 小类:Cardiology and Cardiovascular Medicine Q1 86 / 387

77%

大类:Medicine 小类:Pharmacology (medical) Q2 75 / 272

72%

大类:Medicine 小类:Pharmacology Q2 118 / 313

62%

期刊发文

  • Employing the Sirolimus-Eluting Poly (Propylene Carbonate) Mesh for the Prevention of Arteriovenous Graft Stenosis in Rats.

    Author: Sun H1, Liu CZ1, Liu C1, Tang M1, Cao G1, Zhang Q2, Gu X1.

    Journal: J Cardiovasc Pharmacol Ther. 2019 May;24(3):269-277. doi: 10.1177/1074248418806060. Epub 2018 Nov 26.

  • The Protective Effects of Preconditioning With Dioscin on Myocardial Ischemia/Reperfusion-Induced Ventricular Arrhythmias by Increasing Connexin 43 Expression in Rats.

    Author: Cheng J1, Sun C1, Zhang J2, Zou Q1, Hao Q1, Xue Y1.

    Journal: J Cardiovasc Pharmacol Ther. 2019 May;24(3):262-268. doi: 10.1177/1074248418801567. Epub 2018 Nov 26.

  • Chrysin Suppresses Vascular Endothelial Inflammation via Inhibiting the NF-κB Signaling Pathway.

    Author: Zhao S1,2,3, Liang M2,3, Wang Y2,4, Hu J2,4, Zhong Y2,4, Li J2,4, Huang K2,4, Li Y1,2.

    Journal: J Cardiovasc Pharmacol Ther. 2019 May;24(3):278-287. doi: 10.1177/1074248418810809. Epub 2018 Nov 29.

  • AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.

    Author: Zhao Y1, Ma R1, Yu X1, Li N1, Zhao X1, Yu J1.

    Journal: J Cardiovasc Pharmacol Ther. 2019 Apr 25:1074248419838503. doi: 10.1177/1074248419838503. [Epub ahead of print]

  • Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor 1 of Protein Phosphatase 1 Protects Against Myocardial Ischemia-Reperfusion Injury.

    Author: Yu J1,2, Chen Y1,3, Xu M1, Sun L1, Luo H1, Bao X1, Meng G1,3, Zhang W1.

    Journal: J Cardiovasc Pharmacol Ther. 2019 Apr 28:1074248419841626. doi: 10.1177/1074248419841626. [Epub ahead of print]

  • Resveratrol Attenuates Cardiomyocyte Apoptosis in Rats Induced by Coronary Microembolization Through SIRT1-Mediated Deacetylation of p53.

    Author: Mao Q1,2, Liang X3, Wu Y4, Lu Y2.

    Journal: J Cardiovasc Pharmacol Ther. 2019 May 2:1074248419845916. doi: 10.1177/1074248419845916. [Epub ahead of print]

  • The AMPK Agonist PT1 and mTOR Inhibitor 3HOI-BA-01 Protect Cardiomyocytes After Ischemia Through Induction of Autophagy.

    Author: Huang L, Dai K, Chen M, Zhou W, Wang X, Chen J, Zhou W.

    Journal: J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):70-81. doi: 10.1177/1074248415581177. Epub 2015 Apr 13.

  • Intestinal Barrier Dysfunction: A Novel Therapeutic Target for Inflammatory Response in Acute Stanford Type A Aortic Dissection.

    Author: Gu J, Hu J, Qian H, Shi Y, Zhang E, Guo Y, Xiao Z, Fang Z, Zhong M, Zhang H, Meng W.

    Journal: J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):64-9. doi: 10.1177/1074248415581176. Epub 2015 Apr 21.